Your browser doesn't support javascript.
loading
Comparing patient global impression of severity and patient global impression of change to evaluate test-retest reliability of depression, non-small cell lung cancer, and asthma measures.
Eremenco, Sonya; Chen, Wen-Hung; Blum, Steven I; Bush, Elizabeth Nicole; Bushnell, Donald M; DeBusk, Kendra; Gater, Adam; Nelsen, Linda; Coons, Stephen Joel.
Afiliación
  • Eremenco S; Critical Path Institute, 1730 East River Road, Suite 200, Tucson, AZ, USA. seremenco@c-path.org.
  • Chen WH; GlaxoSmithKline, Collegeville, PA, USA.
  • Blum SI; Bristol Myers Squibb, Lawrenceville, NJ, USA.
  • Bush EN; Eli Lilly and Company, Indianapolis, IN, USA.
  • Bushnell DM; Evidera | PPD, Phoenix, AZ, USA.
  • DeBusk K; Seagen Inc, Bothell, WA, USA.
  • Gater A; Adelphi Values, Bollington, Cheshire, UK.
  • Nelsen L; GlaxoSmithKline, Collegeville, PA, USA.
  • Coons SJ; Critical Path Institute, 1730 East River Road, Suite 200, Tucson, AZ, USA.
Qual Life Res ; 31(12): 3501-3512, 2022 Dec.
Article en En | MEDLINE | ID: mdl-35854060
ABSTRACT

PURPOSE:

Score reproducibility is an important measurement property of fit-for-purpose patient-reported outcome (PRO) measures. It is commonly assessed via test-retest reliability, and best evaluated with a stable participant sample, which can be challenging to identify in diseases with highly variable symptoms. To provide empirical evidence comparing the retrospective (patient global impression of change [PGIC]) and current state (patient global impression of severity [PGIS]) approaches to identifying a stable subgroup for test-retest analyses, 3 PRO Consortium working groups collected data using both items as anchor measures.

METHODS:

The PGIS was completed on Day 1 and Day 8 + 3 for the depression and non-small cell lung cancer (NSCLC) studies, and daily for the asthma study and compared between Day 3 and 10. The PGIC was completed on the final day in each study. Scores were compared using an intraclass correlation coefficient (ICC) for participants who reported "no change" between timepoints for each anchor.

RESULTS:

ICCs using the PGIS "no change" group were higher for depression (0.84 vs. 0.74), nighttime asthma (0.95 vs. 0.53) and daytime asthma (0.86 vs. 0.68) compared to the PGIC "no change" group. ICCs were similar for NSCLC (PGIS 0.87; PGIC 0.85).

CONCLUSION:

When considering anchor measures to identify a stable subgroup for test-retest reliability analyses, current state anchors perform better than retrospective anchors. Researchers should carefully consider the type of anchor selected, the time period covered, and should ensure anchor content is consistent with the target measure concept, as well as inclusion of both current and retrospective anchor measures.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Asma / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Qual Life Res Asunto de la revista: REABILITACAO / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Asma / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Qual Life Res Asunto de la revista: REABILITACAO / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos